Two recent peer-reviewed studies showed clinically significant reductions in the incidence of Postoperative Atrial Fibrillation (POAF) by at least 33% among patients treated with the PleuraFlow® ACT® System.

1. Two recent peer-reviewed studies showed clinically significant reductions in
the incidence of Postoperative Atrial Fibrillation (POAF) by at least 33%1,2
among patients treated with the PleuraFlow® ACT® System*.
Learn more at www.ClearFlow.com
(WE THINK THAT’S A PRETTY BIG DEAL)
References:
1. POAF reduction of 33% (p=0.013) - Sirch, J., Ledwon, M., Puski, T., Boyle,
E.M., Pfeiffer, S., Fischlein, T. Active clearance of chest drainage catheters
reduces retained blood. J Thorac Cardiovasc Surg. 2016. Mar; 151(3):832–838.
2. POAF reduction of 34% (p=0.01) - St-Onge, S., Ben Ali, W., Bouhout, I.,
Bouchard, D., Lamarche, Y., Perrault, L.P., Demers, P. Examining the impact of
active clearance of chest drainage catheters on postoperative atrial fibrillation.
J Thorac Cardiovasc Surg. 2017.
33%
A REDUCTIONIN
POST-OP A-FIB OF
1630 S. Sunkist St., Suite E
Anaheim, California 92806
+1-714-916-5010
+1-844-CLR-FLOW (257-3569)
For PleuraFlow ACT System Indications for
Use, please visit: www.ClearFlow.com/PFI
*
ML204-A